• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解决欧洲转移性乳腺癌服务不足患者群体中的差异和挑战。

Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe.

机构信息

Department of Oncology, University Hospital Center Split, School of Medicine, University of Split, Spinčićeva 1, Split, HR-21.000, Croatia.

Medical Oncology Department, APHP Tenon, 4 Rue de La Chine, Paris, 75020, France.

出版信息

Breast. 2021 Feb;55:79-90. doi: 10.1016/j.breast.2020.12.005. Epub 2020 Dec 13.

DOI:10.1016/j.breast.2020.12.005
PMID:33360479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7772562/
Abstract

People with metastatic breast cancer face many challenges and disparities in obtaining optimal cancer care. These challenges are accentuated in underserved patient populations across Europe, who are less likely to receive quality healthcare for reasons including socioeconomic inequalities, educational or cultural status, or geographic location. While there are many local and national initiatives targeted to address these challenges, there remains a need to reduce disparities and improve access to healthcare to improve outcomes, with a focus on multidisciplinary stakeholder engagement. In October 2019, a range of experts in metastatic breast cancer, including healthcare professionals, patient representatives, policymakers and politicians, met to discuss and prioritize the critical needs of underserved patient populations with metastatic breast cancer in Europe. Six key challenges faced by these communities were identified: the need for amplification of the metastatic breast cancer patient voice, better and wider implementation of high-quality guidelines for metastatic breast cancer, more collaboration between stakeholders, tailored support for patients from different cultural and ethnic backgrounds, improved data sharing, and work-related issues. The Expert Panel then conceived and discussed potential actionable goals to address each key challenge. Their conclusions present a set of interrelated approaches to address the different challenges and could serve as the basis for concerted improvement of the lives of patients with metastatic breast cancer in Europe.

摘要

转移性乳腺癌患者在获得最佳癌症治疗方面面临许多挑战和差异。这些挑战在欧洲服务不足的患者群体中更为突出,他们由于社会经济不平等、教育或文化地位、或地理位置等原因,不太可能获得高质量的医疗保健。尽管有许多针对这些挑战的本地和国家举措,但仍需要减少差异,改善医疗保健的可及性,以改善结果,并侧重于多学科利益相关者的参与。2019 年 10 月,转移性乳腺癌领域的一系列专家,包括医疗保健专业人员、患者代表、政策制定者和政治家,聚在一起讨论并确定欧洲转移性乳腺癌服务不足患者群体的关键需求。确定了这些社区面临的六个关键挑战:需要放大转移性乳腺癌患者的声音,更好地、更广泛地实施高质量的转移性乳腺癌指南,加强利益相关者之间的合作,为来自不同文化和种族背景的患者提供量身定制的支持,改善数据共享,以及与工作相关的问题。专家小组随后构思并讨论了针对每个关键挑战的潜在可操作目标。他们的结论提出了一系列相互关联的方法来应对不同的挑战,可以作为协调改善欧洲转移性乳腺癌患者生活的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f972/7772562/4f542efe2012/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f972/7772562/4c12fa4b4f1e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f972/7772562/4f542efe2012/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f972/7772562/4c12fa4b4f1e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f972/7772562/4f542efe2012/gr2.jpg

相似文献

1
Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe.解决欧洲转移性乳腺癌服务不足患者群体中的差异和挑战。
Breast. 2021 Feb;55:79-90. doi: 10.1016/j.breast.2020.12.005. Epub 2020 Dec 13.
2
EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe.EBCC-14 宣言:解决欧洲转移性乳腺癌患者获得创新治疗机会的差异问题。
Eur J Cancer. 2024 Aug;207:114156. doi: 10.1016/j.ejca.2024.114156. Epub 2024 Jun 7.
3
Global analysis of metastatic breast cancer policy gaps and advocacy efforts across the patient journey.全球范围内转移性乳腺癌政策差距及患者全程中倡导工作的分析。
Breast. 2018 Oct;41:93-106. doi: 10.1016/j.breast.2018.06.005. Epub 2018 Jun 18.
4
End-of-Life Concerns and Experiences of Living With Advanced Breast Cancer Among Medically Underserved Women.医疗资源不足的女性晚期乳腺癌患者的临终关怀问题和生存体验。
J Pain Symptom Manage. 2019 Dec;58(6):959-967. doi: 10.1016/j.jpainsymman.2019.08.006. Epub 2019 Aug 16.
5
Development of an Actionable Framework to Address Cancer Care Disparities in Medically Underserved Populations in the United States: Expert Roundtable Recommendations.制定可行框架以解决美国医疗服务不足人群中的癌症护理差异:专家圆桌会议建议。
JCO Oncol Pract. 2021 Mar;17(3):e278-e293. doi: 10.1200/OP.20.00630. Epub 2021 Jan 18.
6
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
7
Challenges and Solutions to Support Oncology Professionals Serving Underserved Populations With Cancer in the United States: Results From the ASCO Serving the Underserved Task Force.支持美国为癌症患者服务不足人群的肿瘤学专业人员面临的挑战与解决方案:美国临床肿瘤学会服务不足人群特别工作组的结果
JCO Oncol Pract. 2024 May;20(5):688-698. doi: 10.1200/OP.23.00595. Epub 2024 Feb 14.
8
Social workers as patient navigators for breast cancer survivors: what do African-American medically underserved women think of this idea?社会工作者作为乳腺癌幸存者的患者导航员:美国非裔医疗服务不足的女性对这个想法有何看法?
Soc Work Health Care. 2009;48(6):561-78. doi: 10.1080/00981380902765212.
9
Innovative approaches reaching underserved and rural communities to improve epilepsy care: A review of the methodology of the Connectors Project.为改善癫痫护理而接触服务不足社区和农村社区的创新方法:Connectors项目方法综述
Epilepsy Behav. 2019 Jan;90:273-283. doi: 10.1016/j.yebeh.2018.09.029. Epub 2018 Oct 31.
10
Mobile Mammography Participation Among Medically Underserved Women: A Systematic Review.移动乳腺摄影在医疗服务不足妇女中的应用:系统评价。
Prev Chronic Dis. 2018 Nov 15;15:E140. doi: 10.5888/pcd15.180291.

引用本文的文献

1
Underserved Patient Populations With Metastatic Breast Cancer: A Review of Progress and Remaining Challenges.转移性乳腺癌患者的医疗服务不足群体:进展与尚存挑战综述
Breast J. 2025 Jun 30;2025:2461234. doi: 10.1155/tbj/2461234. eCollection 2025.
2
Clinical, Sociodemographic, and Facility-Related Factors Influencing HER2-Targeted Therapy in Metastatic Hormone Receptor-Negative, HER2-Positive Breast Cancer.影响转移性激素受体阴性、HER2阳性乳腺癌HER2靶向治疗的临床、社会人口学及设施相关因素
Cancers (Basel). 2025 May 6;17(9):1579. doi: 10.3390/cancers17091579.
3
Treatment Sequencing in Metastatic HR+/HER2- Breast Cancer: A Delphi Consensus.

本文引用的文献

1
International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus - Assessment by a German Group of Experts.2019年里斯本晚期乳腺癌国际共识会议:ABC5共识——德国专家组评估
Breast Care (Basel). 2020 Feb;15(1):82-95. doi: 10.1159/000505957. Epub 2020 Feb 10.
2
Multidisciplinary team approach in breast cancer care: Benefits and challenges.乳腺癌护理中的多学科团队方法:益处与挑战。
Indian J Pathol Microbiol. 2020 Feb;63(Supplement):S105-S112. doi: 10.4103/IJPM.IJPM_885_19.
3
Atezolizumab for the treatment of breast cancer.
转移性激素受体阳性/人表皮生长因子受体2阴性乳腺癌的治疗顺序:德尔菲共识
Cancers (Basel). 2025 Apr 23;17(9):1412. doi: 10.3390/cancers17091412.
4
Assessing equity of care across metastatic breast cancer treatment junctures: a multi-site retrospective cohort study.评估转移性乳腺癌治疗各阶段的医疗公平性:一项多中心回顾性队列研究。
BMC Cancer. 2025 May 12;25(1):861. doi: 10.1186/s12885-025-14172-2.
5
CDK4/6 inhibitor plus endocrine therapy for advanced breast cancer: results from a web-based survey in Japan.CDK4/6抑制剂联合内分泌治疗晚期乳腺癌:日本一项基于网络调查的结果
Future Oncol. 2025 Feb;21(3):321-330. doi: 10.1080/14796694.2024.2441649. Epub 2024 Dec 20.
6
The treatment pattern of advanced HR-positive and HER2-negative breast cancer in central southern China: a hospital-based cross-sectional study.中国中南地区晚期 HR 阳性、HER2 阴性乳腺癌的治疗模式:一项基于医院的横断面研究。
BMC Cancer. 2024 Jul 30;24(1):915. doi: 10.1186/s12885-024-12665-0.
7
Racialized economic segregation and inequities in treatment initiation and survival among patients with metastatic breast cancer.转移性乳腺癌患者在治疗起始和生存方面存在种族经济隔离和治疗不公平现象。
Breast Cancer Res Treat. 2024 Jul;206(2):411-423. doi: 10.1007/s10549-024-07319-5. Epub 2024 May 3.
8
Cancer of the Cervix in Bulgaria: Epidemiology of a Crisis.保加利亚的宫颈癌:一场危机的流行病学
Healthcare (Basel). 2023 Jan 20;11(3):318. doi: 10.3390/healthcare11030318.
9
How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?欧盟的“战胜癌症计划”如何助力应对肺癌、结直肠癌、乳腺癌和黑色素瘤?
Healthcare (Basel). 2022 Aug 25;10(9):1618. doi: 10.3390/healthcare10091618.
10
Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity.社会经济地位和农村环境对不同种族/族裔的初诊转移性乳腺癌女性癌症特异性生存的影响。
Breast Cancer Res Treat. 2022 Jun;193(3):707-716. doi: 10.1007/s10549-022-06603-6. Epub 2022 Apr 23.
阿替利珠单抗治疗乳腺癌。
Expert Rev Anticancer Ther. 2020 Mar;20(3):151-158. doi: 10.1080/14737140.2020.1732211. Epub 2020 Feb 27.
4
The role of acculturation in migrants' use of gynecologic emergency departments.文化适应在移民使用妇科急诊中的作用。
Int J Gynaecol Obstet. 2020 Apr;149(1):24-30. doi: 10.1002/ijgo.13099. Epub 2020 Jan 28.
5
A feasible and acceptable multicultural psychosocial intervention targeting symptom management in the context of advanced breast cancer.针对晚期乳腺癌症状管理的可行且可接受的多文化心理社会干预。
Psychooncology. 2020 Feb;29(2):389-397. doi: 10.1002/pon.5275. Epub 2019 Nov 19.
6
Health and Racial Disparity in Breast Cancer.乳腺癌的健康与种族差异。
Adv Exp Med Biol. 2019;1152:31-49. doi: 10.1007/978-3-030-20301-6_3.
7
Using Stakeholder Engagement to Overcome Barriers to Implementing Patient-reported Outcomes (PROs) in Cancer Care Delivery: Approaches From 3 Prospective Studies.利用利益相关者参与克服癌症护理提供中实施患者报告结局(PROs)的障碍:来自 3 项前瞻性研究的方法。
Med Care. 2019 May;57 Suppl 5 Suppl 1:S92-S99. doi: 10.1097/MLR.0000000000001103.
8
Breast Cancer Treatment: A Review.乳腺癌治疗:综述。
JAMA. 2019 Jan 22;321(3):288-300. doi: 10.1001/jama.2018.19323.
9
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry.HER2阳性转移性乳腺癌患者的治疗格局:来自PRAEGNANT真实世界乳腺癌登记处的数据。
Cancers (Basel). 2018 Dec 21;11(1):10. doi: 10.3390/cancers11010010.
10
Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics.转移性乳腺癌患者结局的种族/民族差异:人口统计学、社会经济学、肿瘤和转移特征的影响。
Breast Cancer Res Treat. 2019 Jan;173(1):225-237. doi: 10.1007/s10549-018-4956-y. Epub 2018 Oct 6.